Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Glaucoma: Overview01:25

Glaucoma: Overview

1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

934
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
934
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

8.6K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.6K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Neurovascular conflict as a rare cause of internal and external ophthalmoplegia].

Die Ophthalmologie·2024
Same author

[Cornea and conjunctiva].

Klinische Monatsblatter fur Augenheilkunde·2014
Same author

[Paediatric cornea: diagnostics and therapy].

Klinische Monatsblatter fur Augenheilkunde·2013
Same author

[Multicentric study regarding assessment of the driving ability of LASIK and orthokeratology patients compared with conventionally corrected persons].

Klinische Monatsblatter fur Augenheilkunde·2013
Same author

[Diagnostics and therapy for endothelial diseases of the cornea - is there still a gold standard? ].

Klinische Monatsblatter fur Augenheilkunde·2012
Same author

[Biometry of the anterior eye segment for implantation of phakic anterior chamber lenses. A comparison of current measurement devices].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2012
Same journal

The effects of intraocular gases on rabbit blood-retinal barrier permeability.

Lens and eye toxicity research·1992
Same journal

Elemental distribution in frozen-hydrated mouse lenses with hereditary cataract.

Lens and eye toxicity research·1992
Same journal

Lens opacification and H2O2 elevation induced by a tumor promoter.

Lens and eye toxicity research·1992
Same journal

Prevention of galactose cataract by pyruvate.

Lens and eye toxicity research·1992
Same journal

Intraocular silicone oil effects on rabbit blood-retinal barrier permeability.

Lens and eye toxicity research·1992
Same journal

Link between the ciliary process and lens equatorial current.

Lens and eye toxicity research·1992
See all related articles

Related Experiment Videos

Ocular digitalis effects in normal subjects.

G Duncker1, H Krastel

  • 1Department of Ophthalmology, University of Kiel.

Lens and Eye Toxicity Research
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Digitoxin therapy can impair visual functions, including reduced flicker fusion frequency and prolonged color vision recovery. However, some visual pathways remain intact during treatment.

Related Experiment Videos

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Pharmacology

Background:

  • Digitoxin, a cardiac glycoside, is used therapeutically.
  • Visual function can be affected by systemic medications.
  • Understanding the ocular side effects of digitoxin is crucial for patient care.

Purpose of the Study:

  • To investigate the effects of therapeutic digitoxin doses on various visual functions.
  • To assess whether digitoxin impacts neural adaptation processes.
  • To evaluate the ocular toxicity of topical digitoxin application.

Main Methods:

  • Electroretinography (ERG) to measure critical flicker fusion frequency.
  • Color vision tests (Nagel's anomaloscope, Jaeger's tritanomaloscope, Lanthony 15-hue, Farnsworth-Munsell 100-hue).
  • Visual acuity tests, computerized perimetry, and pupillography were employed.

Main Results:

  • Digitoxin reduced critical flicker fusion frequency and prolonged color vision recovery time.
  • Color vision testing showed increased errors, indicating deficits.
  • Topical digitoxin caused toxic keratopathy, which resolved upon discontinuation.

Conclusions:

  • Therapeutic digitoxin doses can induce significant visual disturbances, particularly affecting color vision and flicker fusion frequency.
  • Neural adaptation appears preserved, but color discrimination is impaired.
  • Topical digitoxin exhibits local ocular toxicity, necessitating careful monitoring.